Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The global catheter market size is expected to reach US$ 12,591.3 million in 2023. It is anticipated to witness a CAGR of 6.3% in the forecast period from 2023 to 2033.
The global catheter market is likely to attain a valuation of US$ 23,281.6 million by 2033. It is projected to showcase a valuation of US$ 9,621.3 million in the assessment period.
Rising Use of Silicone in Urinary Catheter Development to Spur Demand
The growing adoption of silicone in the development of urinary catheters is expected to create significant opportunities in the catheter market. Silicone is expected to present emerging opportunities in catheter manufacturing. This is due to its insensitivity to temperature variations and chemical resistance, making it highly preferred among patients opting for catheters.
One notable advantage is the potential reduction in complications such as meatitis, urethritis, and trigonitis when using silicone-based urinary catheters. This is estimated to lead to improved patient outcomes and reduced healthcare costs associated with treating catheter-related infections and discomfort.
The need for central venous catheters is projected to increase as the incidence of cancer, cardiovascular disease, and renal illnesses grows in emerging economies. These are expected to provide manufacturers an opportunity to meet these regions' particular requirements. Ongoing technological advancements, including in antimicrobial and biodegradable catheters, are also set to create new opportunities for catheter manufacturers.
Attributes | Key Insights |
---|---|
Catheter Market Estimated Size (2023E) | US$ 12,591.3 million |
Catheter Market Projected Valuation (2033F) | US$ 23,281.6 million |
Value-based Catheter Market CAGR (2023 to 2033) | 6.3% |
Collective Value Share: Top 5 Countries (2022) | 65.8% |
Controlling Bloodstream Infections Can be a Challenge for Manufacturers
Central venous catheters can carry the risk of causing bloodstream infections as these are used for several medical treatments by inserting them into large central veins. These infections can result in severe complications, prolonged hospitalization, increased healthcare expenses, and even fatalities.
The challenge of preventing and treating bloodstream infections associated with central venous catheters is compounded by antibiotic-resistant pathogens. The overuse and misuse of antibiotics have contributed to the emergence of multidrug-resistant organisms. This makes infections more challenging to control.
In certain instances, the limited effectiveness of antibiotics against specific pathogens can result in treatment failures and complications linked to central line-associated bloodstream infections (CLABSIs). Factors such as high service costs and occasional product recalls are projected to influence the catheter market growth rate negatively.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global catheter market stood at around US$ 11930.3 million in 2022. It expanded at a moderate CAGR of 4.7% in terms of volume in the historical period between 2018 and 2022.
Historical Market Size (2022) | US$ 11930.3 million |
---|---|
Historical Volume-based CAGR (2023 to 2033) | 4.7% |
The ability of catheters to perform diagnostic procedures, such as hemodialysis and electrophysiological studies, is anticipated to be a key factor driving their demand. Globally, the increasing incidence of diseases such as cancer, acute illness, and trauma is projected to lead to a surging demand for efficient medical services. It is estimated to result in an increasing usage of peripherally inserted central catheters (PICC) by healthcare professionals in hospitals, operation theaters, and emergency rooms for effective treatment.
About 17.9 million individuals worldwide passed away in 2019 due to cardiovascular diseases, according to the World Health Organization (WHO) figures for 2021. It also found a rise in cardiovascular mortality in poor and moderate-income countries.
High incidence of cancer is set to be a leading driver for PICC usage, as patients undergoing chemotherapy often require long-term venous access. According to the International Agency for Research on Cancer (IARC), there were 19.3 million new cancer cases and 10 million cancer-related deaths worldwide in 2020. Increasing cancer cases worldwide are expected to augment catheter demand through 2033.
With quicker recovery periods, catheterization is projected to be a treatment of choice for several clinical indications. According to a study published in Methodist Debakey Cardiovasc J, the paradigm of open cardiovascular surgeries is shifting toward minimally invasive procedures as more surgeons are adopting less invasive techniques.
Cardiovascular surgeons must stay updated on the most popular minimally invasive and catheter-based techniques. Patients have grown considerably inclined toward these techniques due to the advantages of less blood loss, shorter hospital stays, decreased postoperative pain, and improved cosmesis. These developments are set to make the procedures safe and effective.
The table below provides the latest trends in the global catheter market, growth obstacles, and upcoming opportunities. Choosing appropriate business strategies for the catheter market can enable stakeholders to invest in the right area and gain profit.
Attributes | Key Factors |
---|---|
Latest Trends |
|
Upcoming Opportunities |
|
Challenges |
|
The global catheter market is likely to be impacted by the peer or tangential markets in the healthcare sector. These include other markets such as the catheter-directed thrombolysis and catheter-related bloodstream infection (CRBSI) markets. The global sales outlook of the catheter industry can provide deeper insights that can help develop unique differentiating strategies to pursue growth and opportunity.
Out of the three markets, the catheter market is set to dominate, followed by the catheter-directed thrombolysis market, with valuations of US$ 12,591.3 million and US$ 454.8 million in 2023, respectively. All three markets are anticipated to expand amid ongoing development in the healthcare sector to unveil cutting-edge medical products.
Catheter Market:
Attributes | Catheter Market |
---|---|
CAGR (2023 to 2033) | 6.3% |
Market Value (2023) | US$ 12,591.3 million |
Growth Factor | Launch of novel catheters equipped with enhanced guidance systems, high compatibility with imaging equipment, and improved visibility is projected to drive catheter sales. |
Key Trend | Rising geriatric population globally is set to propel the prevalence of urinary incontinence and cardiovascular diseases, thereby creating a high catheter demand through 2033. |
Catheter-directed Thrombolysis Market:
Attributes | Catheter-directed Thrombolysis Market |
---|---|
CAGR (2023 to 2033) | 5.9% |
Market Value (2023) | US$ 454.8 million |
Growth Factor | Rising prevalence of deep vein thrombosis is expected to drive the demand in the global market as catheter-directed thrombolysis is considered an ideal treatment option. |
Key Trend | Growing inclination toward outpatient treatment of several thrombotic conditions amid innovations in catheter protocols and technology is set to be a leading trend. |
Catheter-related Bloodstream Infection (CRBSI) Market:
Attributes | Catheter-related Bloodstream Infection (CRBSI) Market |
---|---|
CAGR (2023 to 2033) | 6% |
Market Value (2023) | US$ 44.67 billion |
Growth Factor | Increasing adoption of antimicrobial catheters is set to be a key driving factor as these are made to lower the risk of bacterial colonization and bloodstream infections related to the use of catheters. |
Key Trend | Strict norms implemented by healthcare authorities are projected to emphasize the significance of infection control, which is expected to drive the use of innovative catheter technologies. |
In the below table of the growth potential of the catheter market, CAGRs of the top 5 countries are provided. Out of the 5, India is likely to lead the catheter market by exhibiting a CAGR of 8.2% from 2023 to 2033. China and Germany are expected to witness catheter sales at the CAGRs of 7.4% and 6.4%, respectively.
Countries | Value-based CAGR |
---|---|
United States | 6.0% |
China | 7.4% |
Germany | 6.4% |
United Kingdom | 6.1% |
India | 8.2% |
The United States catheter market is expected to be highly profitable in the review period. It held a global catheter market share of around 35.2% in 2022. The country will likely register a CAGR of 6.0% during the forecast period.
Growth in the United States is attributed to an extensive healthcare infrastructure, including hospitals, clinics, and research institutions. These facilities are anticipated to create a skyrocketing demand for medical devices such as catheters. The United States is also considered a center for medical innovation and research. It is expected to invest significantly in creating and implementing cutting-edge medical technology.
Innovations include sophisticated catheter designs and materials. It has a robust healthcare infrastructure, substantial healthcare spending, and a keen interest in cutting-edge technology advancements, all of which are expected to aid catheter sales.
China is projected to be one of the most attractive catheter markets globally 2033. It accounted for a steady market share of around 9.7% in 2022. Several factors contribute to significant market growth rates in emerging economies such as China.
Increased healthcare spending in the country is a key driver. Additionally, substantial untapped opportunities in the country are expected to be a key driver.The substantial patient population dealing with kidney and cardiovascular issues, coupled with improvements in healthcare infrastructure, is set to push market expansion in China. Favorable government policies and the increasing introduction of new products are a couple of other factors augmenting demand in the country.
As per a study published in the Clinical Kidney Journal, 88,271 (1.26%) of the 9.5 million people in China had chronic kidney disease (CKD) in December 2022. For stages 3, 4, and 5, the prevalence rates of CKD were 1.20%, 0.04%, and 0.02%, respectively.
The entire incidence rate of CKD was 1.07% after adjusting for the ratio and incidence in urban and rural areas, meaning that around 14 million adults in China suffer from the disease. The frequency of CKD was 1.8 times greater in women than in males, and it increased three times for every decade of age. The country's increasing prevalence of such chronic illnesses is projected to bolster catheter demand through 2033.
India is projected to witness a CAGR of 8.2% from 2023 to 2033 in the catheter market. The pharmaceutical and medical equipment industries in India have expanded dramatically over the past ten years. India is expected to produce a wide range of medical equipment, from implantable to consumable items, including catheters.
In November 2021, for instance, a leading medical technology provider in India, Medtronic, introduced the Arctic Front Cardiac Cryoablation Catheter System for managing atrial fibrillation (AF). To prevent the body from receiving harmful electrical signals, the cryoballoon catheter addresses pulmonary vein isolation, effectively treating AF. Several regulatory agencies have recognized its efficacy and safety, and it is also used to treat more than a million patients worldwide.
In October 2022, on the other hand, DY Patil Medical College opened its advanced bi-plane cardiac catheterization laboratory. It is considered the first-ever model of IGS 6 and catheterization lab in South Asia. It was created in collaboration with Wipro GE Healthcare. Similar innovations in India are anticipated to drive demand for catheters.
Germany is expected to rise at a decent CAGR of about 6.4% in the assessment period in the catheter market. The growing prevalence of cardiovascular conditions and diabetes in the country is projected to aid catheter demand.
According to the German Centers for Health Research, around 8.5 million people in Germany have diabetes. An estimated 2 million people with diabetes have not been diagnosed in the country. In the following twenty years, type 2 diabetes will become more prevalent in Germany. By 2040, up to 12 million individuals could have the metabolic disorder, according to researchers. The increasing prevalence of the disease in the forecast period is set to support demand.
The United Kingdom is estimated to register an average CAGR of 6.1% during the forecast period in the catheter market. Similar to several developed economies, the United Kingdom has a substantial geriatric population.
The country's increasing number of senior citizens will likely pose a high risk of age-related health conditions. Such chronic medical conditions are anticipated to need the intervention of catheters for management, including cardiovascular diseases and urinary incontinence.
According to the National Health Service (NHS), around 3 to 6 million individuals in the United Kingdom suffer from a certain level of urinary incontinence. It is expected to be more common in women than in men.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below highlights the global demand for catheters by product. Under products, the intravenous catheter segment will likely remain dominant in the assessment period.
The intravenous catheters segment, while smaller, is set to showcase a significant CAGR of 7.5% through 2033 in the catheter market. It is expected to be followed by urinary catheter and hemodialysis catheter segments.
Products | Value-based CAGR |
---|---|
Urinary Catheters | 7.0% |
Intravenous Catheters | 7.5% |
Hemodialysis Catheters | 5.5% |
The intravenous catheters segment accounted for a dominant share of 64.4% 2022 in the global catheter market. Modern medicine relies heavily on IV catheters as they make it possible to provide patients with fluids, drugs, and nutrition right into their bloodstream. It will likely remain crucial for various medical procedures, such as pain control, chemotherapy, antibiotic therapy, and hydration. Additionally, they are expected to provide accurate and speedy medicine delivery.
Intravenous catheters can deliver drugs more effectively and rapidly than conventional routes, another key factor driving its renown. Furthermore, it is projected that technical advances made by the leading players in this industry will fuel the segment’s growth.
The table below highlights the global demand for catheters by indication. Under indication, the acute kidney injury segment will likely remain dominant in the assessment period.
While smaller, the acute kidney injury segment is set to showcase a significant CAGR of 8.1% through 2033 in the catheter market. It is expected to be followed by urinary incontinence, urethral stricture, chronic obstruction, neurogenic bladder, enlarged prostate gland/BPH, and other segments.
Indication | Value-based CAGR |
---|---|
Urinary Incontinence | 6.0% |
Urethral Stricture | 6.6% |
Chronic Obstruction | 7.2% |
Neurogenic Bladder | 7.5% |
Enlarged Prostate Gland/BPH | 5.3% |
Prostate Cancer | 5.7% |
Acute Kidney Injury | 8.1% |
Others | 4.8% |
Though the acute kidney injury segment is estimated to remain dominant by exhibiting a CAGR of 8.1% in the forecast period, the urinary incontinence segment will likely follow. The latter generated a considerable catheter market share of 24.6% in 2022.
Catheterization, a frequently used medical strategy to effectively control this illness, is set to result in high usage of catheters in treatment of urinary incontinence. By emptying urine from the bladder directly into a collecting bag, catheters are projected to temporarily relieve urinary incontinence in sufferers, thereby driving their demand.
This is considered very helpful for when other procedures or method do not act as effectively. Catheters are expected to provide a dependable method of regulating urine drainage and minimizing leaks for those with severe urinary incontinence.
They are ideal for patients who cannot control their bladder functions owing to neurological problems or other medical concerns. They are also expected to offer several advantages following surgery, including continuous urine drainage.
The table below highlights the global demand for catheters by end-use. Under end-use, the hospital segment will likely remain dominant in the assessment period.
The hospital segment, while smaller, is set to showcase a significant CAGR of 5.7% through 2033 in the catheter market. It is expected to be followed by dialysis centers, long-term care facilities, ambulatory surgical centers, and home care segments.
End-user | Value-based CAGR |
---|---|
Hospitals | 5.7% |
Dialysis Centers | 7.6% |
Long-term Care Facilities | 6.7% |
Ambulatory Surgical Centers | 5.1% |
Home Care | 7.0% |
During the evaluation period, the hospital segment is projected to be a leading end-user in the catheter market. It generated a 48.4% value share in 2022 due to the increasing surgical operations that call for the use of catheters to infuse IV solutions and fluids.
Rising hospital admission rates internationally are also expected to bolster demand. In hospitals, catheter-based procedures are set to guarantee the prompt and precise distribution of drugs.
Catheters are estimated to be essential for patients in critical conditions or those requiring specialized treatments. Additionally, several surgical procedures are set to require catheters, making them unique in hospitals.
Prominent players in the catheter market are prioritizing the enhancement of product features as a means to bolster their positions. Additionally, they are keen on extending their presence in emerging markets.
A central strategy embraced by leading manufacturers to maintain leadership in the catheter market involves entering into strategic partnerships and agreements with other companies. These strategies are anticipated to help them in expanding their business reach.
Key players also focus on optimizing their manufacturing processes to reduce manufacturing costs. They are investing considerable sums in advanced supply chain management solutions to lower the total overheads and transportation costs.
For instance,
Attribute | Details |
---|---|
Estimated Catheter Market Size (2023) | US$ 12,591.3 million |
Projected Catheter Market Valuation (2033) | US$ 23,281.6 million |
Value-based Catheter Market CAGR (2023 to 2033) | 6.3% |
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Catheter Market Analysis | Value (US$ million) |
Key Regions Covered in Catheter Market | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
Key Countries Covered in Catheter Market | United States, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa. |
Key Segments Covered in Catheter Market | Product, Indication, End-user, and Region |
Key Companies Profiled in Catheter Market |
|
Catheter Market Report Coverage | Market Forecast, Competition Intelligence, Market Dynamics and Challenges, Strategic Growth Initiatives |
The global catheter market is set to reach US$ 23,281.6 million in 2033.
Manufacturers of urinary catheters are expected to use silicone to reduce complications.
Colopast, Medtronic, and Sterimed Group are the leading catheter manufacturers.
Urinary, intravenous, and hemodialysis are the three types of catheters.
The rising demand for minimally invasive surgical procedures is a key trend.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption/Usage Analysis 4.2. Products USP/ Features Analysis 4.3. Regulatory Landscape 4.3.1. Regulatory Frameworks in United States 4.3.2. Regulatory Frameworks in Europe 4.3.3. Regulatory Frameworks in India 4.3.4. Regulatory Frameworks in Australia 4.4. Disease Epidemiology, By Region 4.5. PESTLE Analysis 4.6. Porter’s Analysis 4.7. Product USP Analysis 4.8. Value Chain Analysis 4.9. Unmet Needs 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Industry Growth Outlook 5.1.2. Global Medical Devices Growth Outlook 5.1.3. Growing Geriatric Population 5.1.4. Global Medical Device Market Overview – Parent Market Analysis 5.2. Forecast Factors - Relevance and Impact 5.2.1. Historical Growth of Top Companies 5.2.2. Increasing Adoption of Advanced Central Venous Catheters Kits 5.2.3. Prevalence of Chronic Diseases 5.2.4. New Product Launch 5.2.5. GDP Growth 5.2.6. Increasing Number of Diagnostic Laboratories 5.2.7. Rising Funding for Research Activities 5.2.8. Regulatory Dynamics 5.2.9. Implementation of Quality Improvement (QI) Programs 5.2.10. Develop Innovative Approaches to Combat Urinary Tract Infections 5.2.11. Rising Availability of Different Types of Indwelling Catheters 5.2.12. Rise in R&D Expenditure 5.2.13. Cost of Product 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand (in Volume) Analysis 2018 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Volume (Units) Analysis, 2018 to 2022 6.2. Current and Future Market Volume (Units) Analysis and Forecast, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market - Pricing Assessment 7.1. Regional Pricing Analysis 7.2. Pricing Break-up 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ million) Analysis 2018 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ million) Analysis, 2018 to 2022 8.2. Current and Future Market Size (US$ million) Analysis and Forecast, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Product, 2018 to 2022 9.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Product, 2023 to 2033 9.3.1. Urinary Catheters 9.3.1.1. Foley Catheters 9.3.1.2. Intermittent Catheters 9.3.1.3. External Catheters 9.3.1.4. Compact Catheters 9.3.2. Intravenous Catheters 9.3.2.1. Peripheral Catheters 9.3.2.1.1. Short Peripheral IV Catheter 9.3.2.1.2. Integrated/Closed PIVC 9.3.2.2. Central Venous Catheters 9.3.2.2.1. Peripherally Inserted Central Catheters (PICC) 9.3.2.2.2. Implanted Port 9.3.2.2.3. Tunneled Central Venous Catheters 9.3.2.2.4. Non-tunneled Central Venous Catheters 9.3.3. Hemodialysis Catheters 9.3.3.1. Cuffed Tunneled Catheter 9.3.3.2. Non-cuffed Tunneled Catheters 9.3.3.3. Non-tunneled Catheters 9.4. Market Attractiveness Analysis by Product 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ million) Analysis by Indication, 2018 to 2022 10.3. Current and Future Market Size (US$ million) Analysis and Forecast by Indication, 2023 to 2033 10.3.1. Urinary Incontinence 10.3.2. Urethral Stricture 10.3.3. Chronic Obstruction 10.3.4. Neurogenic Bladder 10.3.5. Enlarged Prostate Gland/BPH 10.3.6. Prostate Cancer 10.3.7. Acute Kidney Injury 10.3.8. Others 10.4. Market Attractiveness Analysis by Indication 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-user 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ million) Analysis by End-user, 2018 to 2022 11.3. Current and Future Market Size (US$ million) Analysis and Forecast by End-user, 2023 to 2033 11.3.1. Hospitals 11.3.2. Dialysis Centers 11.3.3. Long-term Care Facilities 11.3.4. Ambulatory Surgical Centers 11.3.5. Home Care 11.4. Market Attractiveness Analysis by End-user 12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Region, 2018 to 2022 12.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Region, 2023 to 2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. South Asia 12.3.5. East Asia 12.3.6. Oceania 12.3.7. Middle East and Africa 12.4. Market Attractiveness Analysis by Region 13. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ million) and Volume (Units) Analysis, By Market Taxonomy, 2018 to 2022 13.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. United States 13.3.1.2. Canada 13.3.2. By Product 13.3.3. By Indication 13.3.4. By End-user 13.4. Market Attractiveness Analysis by Region 13.4.1. By Country 13.4.2. By Product 13.4.3. By Indication 13.4.4. By End-user 13.5. Market trends 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 13.8. Country Level Analysis and Forecast 13.8.1. United States Market Analysis 13.8.1.1. Introduction 13.8.1.2. Market Analysis and Forecast by Market Taxonomy 13.8.1.2.1. By Product 13.8.1.2.2. By Indication 13.8.1.2.3. By End-user 13.8.2. Canada Market Analysis 13.8.2.1. Introduction 13.8.2.2. Market Analysis and Forecast by Market Taxonomy 13.8.2.2.1. By Product 13.8.2.2.2. By Indication 13.8.2.2.3. By End-user 14. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ million) and Volume (Units) Analysis, By Market Taxonomy, 2018 to 2022 14.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product 14.3.3. By Indication 14.3.4. By End-user 14.4. Market Attractiveness Analysis by Region 14.4.1. By Country 14.4.2. By Product 14.4.3. By Indication 14.4.4. By End-user 14.5. Market trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country Level Analysis and Forecast 14.8.1. Brazil Market Analysis 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast by Market Taxonomy 14.8.1.2.1. By Product 14.8.1.2.2. By Indication 14.8.1.2.3. By End-user 14.8.2. Mexico Market Analysis 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast by Market Taxonomy 14.8.2.2.1. By Product 14.8.2.2.2. By Indication 14.8.2.2.3. By End-user 14.8.3. Argentina Market Analysis 14.8.3.1. Introduction 14.8.3.2. Market Analysis and Forecast by Market Taxonomy 14.8.3.2.1. By Product 14.8.3.2.2. By Indication 14.8.3.2.3. By End-user 15. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ million) and Volume (Units) Analysis, By Market Taxonomy, 2018 to 2022 15.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. United Kingdom 15.3.1.2. Germany 15.3.1.3. Italy 15.3.1.4. France 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. BENELUX 15.3.1.8. Rest of Europe 15.3.2. By Product 15.3.3. By Indication 15.3.4. By End-user 15.4. Market Attractiveness Analysis by Region 15.4.1. By Country 15.4.2. By Product 15.4.3. By Indication 15.4.4. By End-user 15.5. Market trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country Level Analysis and Forecast 15.8.1. United Kingdom Market Analysis 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Product 15.8.1.2.2. By Indication 15.8.1.2.3. By End-user 15.8.2. Germany Market Analysis 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Product 15.8.2.2.2. By Indication 15.8.2.2.3. By End-user 15.8.3. Italy Market Analysis 15.8.3.1. Introduction 15.8.3.2. Market Analysis and Forecast by Market Taxonomy 15.8.3.2.1. By Product 15.8.3.2.2. By Indication 15.8.3.2.3. By End-user 15.8.4. France Market Analysis 15.8.4.1. Introduction 15.8.4.2. Market Analysis and Forecast by Market Taxonomy 15.8.4.2.1. By Product 15.8.4.2.2. By Indication 15.8.4.2.3. By End-user 15.8.5. Spain Market Analysis 15.8.5.1. Introduction 15.8.5.2. Market Analysis and Forecast by Market Taxonomy 15.8.5.2.1. By Product 15.8.5.2.2. By Indication 15.8.5.2.3. By End-user 15.8.6. Russia Market Analysis 15.8.6.1. Introduction 15.8.6.2. Market Analysis and Forecast by Market Taxonomy 15.8.6.2.1. By Product 15.8.6.2.2. By Indication 15.8.6.2.3. By End-user 15.8.7. BENELUX Market Analysis 15.8.7.1. Introduction 15.8.7.2. Market Analysis and Forecast by Market Taxonomy 15.8.7.2.1. By Product 15.8.7.2.2. By Indication 15.8.7.2.3. By End-user 16. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Introduction / Key Findings 16.2. Historical Market Size (US$ million) and Volume (Units) Analysis, By Market Taxonomy, 2018 to 2022 16.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Indonesia 16.3.1.3. Thailand 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.3.3. By Indication 16.3.4. By End-user 16.4. Market Attractiveness Analysis by Region 16.4.1. By Country 16.4.2. By Product 16.4.3. By Indication 16.4.4. By End-user 16.5. Market trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country Level Analysis and Forecast 16.8.1. India Market Analysis 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Product 16.8.1.2.2. By Indication 16.8.1.2.3. By End-user 16.8.2. Indonesia Market Analysis 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Product 16.8.2.2.2. By Indication 16.8.2.2.3. By End-user 16.8.3. Thailand Market Analysis 16.8.3.1. Introduction 16.8.3.2. Market Analysis and Forecast by Market Taxonomy 16.8.3.2.1. By Product 16.8.3.2.2. By Indication 16.8.3.2.3. By End-user 16.8.4. Malaysia Market Analysis 16.8.4.1. Introduction 16.8.4.2. Market Analysis and Forecast by Market Taxonomy 16.8.4.2.1. By Product 16.8.4.2.2. By Indication 16.8.4.2.3. By End-user 17. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17.1. Introduction / Key Findings 17.2. Historical Market Size (US$ million) and Volume (Units) Analysis, By Market Taxonomy, 2018 to 2022 17.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product 17.3.3. By Indication 17.3.4. By End-user 17.4. Market Attractiveness Analysis by Region 17.4.1. By Country 17.4.2. By Product 17.4.3. By Indication 17.4.4. By End-user 17.5. Market trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis and Forecast 17.8.1. China Market Analysis 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Product 17.8.1.2.2. By Indication 17.8.1.2.3. By End-user 17.8.2. Japan Market Analysis 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Product 17.8.2.2.2. By Indication 17.8.2.2.3. By End-user 17.8.3. South Korea Market Analysis 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Product 17.8.3.2.2. By Indication 17.8.3.2.3. By End-user 18. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 18.1. Introduction / Key Findings 18.2. Historical Market Size (US$ million) and Volume (Units) Analysis, By Market Taxonomy, 2018 to 2022 18.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By Indication 18.3.4. By End-user 18.4. Market Attractiveness Analysis by Region 18.4.1. By Country 18.4.2. By Product 18.4.3. By Indication 18.4.4. By End-user 18.5. Market trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country Level Analysis and Forecast 18.8.1. Australia Market Analysis 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Product 18.8.1.2.2. By Indication 18.8.1.2.3. By End-user 18.8.2. New Zealand Market Analysis 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Product 18.8.2.2.2. By Indication 18.8.2.2.3. By End-user 19. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 19.1. Introduction / Key Findings 19.2. Historical Market Size (US$ million) and Volume (Units) Analysis, By Market Taxonomy, 2018 to 2022 19.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Türkiye 19.3.1.3. South Africa 19.3.1.4. Northern Africa 19.3.1.5. Rest of Middle East and Africa 19.3.2. By Product 19.3.3. By Indication 19.3.4. By End-user 19.4. Market Attractiveness Analysis by Region 19.4.1. By Country 19.4.2. By Product 19.4.3. By Indication 19.4.4. By End-user 19.5. Market trends 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Country Level Analysis and Forecast 19.8.1. GCC Countries Market Analysis 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast by Market Taxonomy 19.8.1.2.1. By Product 19.8.1.2.2. By Indication 19.8.1.2.3. By End-user 19.8.2. Türkiye Market Analysis 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast by Market Taxonomy 19.8.2.2.1. By Product 19.8.2.2.2. By Indication 19.8.2.2.3. By End-user 19.8.3. South Africa Market Analysis 19.8.3.1. Introduction 19.8.3.2. Market Analysis and Forecast by Market Taxonomy 19.8.3.2.1. By Product 19.8.3.2.2. By Indication 19.8.3.2.3. By End-user 19.8.4. Northern Africa Market Analysis 19.8.4.1. Introduction 19.8.4.2. Market Analysis and Forecast by Market Taxonomy 19.8.4.2.1. By Product 19.8.4.2.2. By Indication 19.8.4.2.3. By End-user 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Share Analysis of Top Players (%) 20.3. Market Concentration 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Deep Dive 21.2.1. Becton, Dickinson & Company 21.2.1.1. Overview 21.2.1.2. Product Portfolio 21.2.1.3. Key Financials 21.2.1.4. Sales Footprint 21.2.1.5. SWOT Analysis 21.2.1.6. Strategy Overview 21.2.1.6.1. Marketing Strategies 21.2.1.6.2. Product Strategies 21.2.1.6.3. Channel Strategies 21.2.2. Cardinal Health 21.2.2.1. Overview 21.2.2.2. Product Portfolio 21.2.2.3. Key Financials 21.2.2.4. Sales Footprint 21.2.2.5. SWOT Analysis 21.2.2.6. Strategy Overview 21.2.2.6.1. Marketing Strategies 21.2.2.6.2. Product Strategies 21.2.2.6.3. Channel Strategies 21.2.3. B. Braun Melsungen AG 21.2.3.1. Overview 21.2.3.2. Product Portfolio 21.2.3.3. Key Financials 21.2.3.4. Sales Footprint 21.2.3.5. SWOT Analysis 21.2.3.6. Strategy Overview 21.2.3.6.1. Marketing Strategies 21.2.3.6.2. Product Strategies 21.2.3.6.3. Channel Strategies 21.2.4. Coloplast 21.2.4.1. Overview 21.2.4.2. Product Portfolio 21.2.4.3. Key Financials 21.2.4.4. Sales Footprint 21.2.4.5. SWOT Analysis 21.2.4.6. Strategy Overview 21.2.4.6.1. Marketing Strategies 21.2.4.6.2. Product Strategies 21.2.4.6.3. Channel Strategies 21.2.5. Medtronic 21.2.5.1. Overview 21.2.5.2. Product Portfolio 21.2.5.3. Key Financials 21.2.5.4. Sales Footprint 21.2.5.5. SWOT Analysis 21.2.5.6. Strategy Overview 21.2.5.6.1. Marketing Strategies 21.2.5.6.2. Product Strategies 21.2.5.6.3. Channel Strategies 21.2.6. ConvaTec Inc. 21.2.6.1. Overview 21.2.6.2. Product Portfolio 21.2.6.3. Key Financials 21.2.6.4. Sales Footprint 21.2.6.5. SWOT Analysis 21.2.6.6. Strategy Overview 21.2.6.6.1. Marketing Strategies 21.2.6.6.2. Product Strategies 21.2.6.6.3. Channel Strategies 21.2.7. Teleflex Inc. 21.2.7.1. Overview 21.2.7.2. Product Portfolio 21.2.7.3. Key Financials 21.2.7.4. Sales Footprint 21.2.7.5. SWOT Analysis 21.2.7.6. Strategy Overview 21.2.7.6.1. Marketing Strategies 21.2.7.6.2. Product Strategies 21.2.7.6.3. Channel Strategies 21.2.8. Stryker Corporation (Cerus Endovascular) 21.2.8.1. Overview 21.2.8.2. Product Portfolio 21.2.8.3. Key Financials 21.2.8.4. Sales Footprint 21.2.8.5. SWOT Analysis 21.2.8.6. Strategy Overview 21.2.8.6.1. Marketing Strategies 21.2.8.6.2. Product Strategies 21.2.8.6.3. Channel Strategies 21.2.9. Sterimed Group 21.2.9.1. Overview 21.2.9.2. Product Portfolio 21.2.9.3. Key Financials 21.2.9.4. Sales Footprint 21.2.9.5. SWOT Analysis 21.2.9.6. Strategy Overview 21.2.9.6.1. Marketing Strategies 21.2.9.6.2. Product Strategies 21.2.9.6.3. Channel Strategies 21.2.10. VOGT Medical 21.2.10.1. Overview 21.2.10.2. Product Portfolio 21.2.10.3. Key Financials 21.2.10.4. Sales Footprint 21.2.10.5. SWOT Analysis 21.2.10.6. Strategy Overview 21.2.10.6.1. Marketing Strategies 21.2.10.6.2. Product Strategies 21.2.10.6.3. Channel Strategies 21.2.11. Optimum Medical Limited 21.2.11.1. Overview 21.2.11.2. Product Portfolio 21.2.11.3. Key Financials 21.2.11.4. Sales Footprint 21.2.11.5. SWOT Analysis 21.2.11.6. Strategy Overview 21.2.11.6.1. Marketing Strategies 21.2.11.6.2. Product Strategies 21.2.11.6.3. Channel Strategies 21.2.12. Insung Medical 21.2.12.1. Overview 21.2.12.2. Product Portfolio 21.2.12.3. Key Financials 21.2.12.4. Sales Footprint 21.2.12.5. SWOT Analysis 21.2.12.6. Strategy Overview 21.2.12.6.1. Marketing Strategies 21.2.12.6.2. Product Strategies 21.2.12.6.3. Channel Strategies 21.2.13. BACTIGUARD AB 21.2.13.1. Overview 21.2.13.2. Product Portfolio 21.2.13.3. Key Financials 21.2.13.4. Sales Footprint 21.2.13.5. SWOT Analysis 21.2.13.6. Strategy Overview 21.2.13.6.1. Marketing Strategies 21.2.13.6.2. Product Strategies 21.2.13.6.3. Channel Strategies 21.2.14. Polymedicure 21.2.14.1. Overview 21.2.14.2. Product Portfolio 21.2.14.3. Key Financials 21.2.14.4. Sales Footprint 21.2.14.5. SWOT Analysis 21.2.14.6. Strategy Overview 21.2.14.6.1. Marketing Strategies 21.2.14.6.2. Product Strategies 21.2.14.6.3. Channel Strategies 21.2.15. Utah Medical Products, Inc. 21.2.15.1. Overview 21.2.15.2. Product Portfolio 21.2.15.3. Key Financials 21.2.15.4. Sales Footprint 21.2.15.5. SWOT Analysis 21.2.15.6. Strategy Overview 21.2.15.6.1. Marketing Strategies 21.2.15.6.2. Product Strategies 21.2.15.6.3. Channel Strategies 21.2.16. Smiths Medical 21.2.16.1. Overview 21.2.16.2. Product Portfolio 21.2.16.3. Key Financials 21.2.16.4. Sales Footprint 21.2.16.5. SWOT Analysis 21.2.16.6. Strategy Overview 21.2.16.6.1. Marketing Strategies 21.2.16.6.2. Product Strategies 21.2.16.6.3. Channel Strategies 21.2.17. Argon Medical Devices, Inc. 21.2.17.1. Overview 21.2.17.2. Product Portfolio 21.2.17.3. Key Financials 21.2.17.4. Sales Footprint 21.2.17.5. SWOT Analysis 21.2.17.6. Strategy Overview 21.2.17.6.1. Marketing Strategies 21.2.17.6.2. Product Strategies 21.2.17.6.3. Channel Strategies 21.2.18. Boston Scientific Corporation 21.2.18.1. Overview 21.2.18.2. Product Portfolio 21.2.18.3. Key Financials 21.2.18.4. Sales Footprint 21.2.18.5. SWOT Analysis 21.2.18.6. Strategy Overview 21.2.18.6.1. Marketing Strategies 21.2.18.6.2. Product Strategies 21.2.18.6.3. Channel Strategies 21.2.19. Cook Medical Incorporated 21.2.19.1. Overview 21.2.19.2. Product Portfolio 21.2.19.3. Key Financials 21.2.19.4. Sales Footprint 21.2.19.5. SWOT Analysis 21.2.19.6. Strategy Overview 21.2.19.6.1. Marketing Strategies 21.2.19.6.2. Product Strategies 21.2.19.6.3. Channel Strategies 21.2.20. Fresenius Kabi AG 21.2.20.1. Overview 21.2.20.2. Product Portfolio 21.2.20.3. Key Financials 21.2.20.4. Sales Footprint 21.2.20.5. SWOT Analysis 21.2.20.6. Strategy Overview 21.2.20.6.1. Marketing Strategies 21.2.20.6.2. Product Strategies 21.2.20.6.3. Channel Strategies 22. Assumptions and Acronyms Used 23. Research Methodology
Table 1: Global Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 2: Global Market Volume (Units) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 3: Global Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Indication Table 4: Global Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By End-user Table 5: Global Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Region Table 6: Global Market Volume (Units) Analysis and Opportunity Assessment 2018 to 2022, By Region Table 7: North America Market Value (US$ million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country Table 8: North America Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 9: North America Market Volume (Units) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 10: North America Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Indication Table 11: North America Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By End-user Table 12: Latin America Market Value (US$ million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country Table 13: Latin America Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 14: Latin America Market Volume (Units) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 15: Latin America Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Indication Table 16: Latin America Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By End-user Table 17: Europe Market Value (US$ million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country Table 18: Europe Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 19: Europe Market Volume (Units) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 20: Europe Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Indication Table 21: Europe Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By End-user Table 22: South Asia Market Value (US$ million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country Table 23: South Asia Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 24: South Asia Market Volume (Units) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 25: South Asia Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Indication Table 26: South Asia Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By End-user Table 27: East Asia Market Value (US$ million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country Table 28: East Asia Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 29: East Asia Market Volume (Units) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 30: East Asia Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Indication Table 31: East Asia Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By End-user Table 32: Oceania Market Value (US$ million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country Table 33: Oceania Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 34: Oceania Market Volume (Units) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 35: Oceania Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Indication Table 36: Oceania Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By End-user Table 37: Middle East and Africa Market Value (US$ million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country Table 38: Middle East and Africa Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 39: Middle East and Africa Market Volume (Units) Analysis and Opportunity Assessment 2018 to 2033, By Product Table 40: Middle East and Africa Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By Indication Table 41: Middle East and Africa Market Value (US$ million) Analysis and Opportunity Assessment 2018 to 2033, By End-user
Figure 1: Global Market Volume (Units), 2018 to 2022 Figure 2: Global Market Volume (Units) and Y-o-Y Growth (%) Analysis, 2023 to 2033 Figure 3: Global Market, Pricing Analysis per unit (US$), in 2022 Figure 4: Global Market, Pricing Forecast per unit (US$), in 2033 Figure 5: Global Market Value (US$ million) Analysis, 2018 to 2022 Figure 6: Global Market Forecast and Y-o-Y Growth, 2023 to 2033 Figure 7: Global Market Absolute $ Opportunity (US$ million) Analysis, 2023 Figure 8: Global Market Value Share (%) Analysis 2023 and 2033, By Product Figure 9: Global Market Y-o-Y Growth (%) Analysis 2023 to 2033, By Product Figure 10: Global Market Attractiveness Analysis 2023 to 2033, By Product Figure 11: Global Market Value Share (%) Analysis 2023 and 2033, By Indication Figure 12: Global Market Y-o-Y Growth (%) Analysis 2023 to 2033, By Indication Figure 13: Global Market Attractiveness Analysis 2023 to 2033, By Indication Figure 14: Global Market Value Share (%) Analysis 2023 and 2033, By End-user Figure 15: Global Market Y-o-Y Growth (%) Analysis 2023 to 2033, By End-user Figure 16: Global Market Attractiveness Analysis 2023 to 2033, By End-user Figure 17: Global Market Value Share (%) Analysis 2023 and 2033, By Region Figure 18: Global Market Y-o-Y Growth (%) Analysis 2023 to 2033, By Region Figure 19: Global Market Attractiveness Analysis 2023 to 2033, By Region Figure 20: North America Market Value (US$ million) Analysis, 2018 to 2022 Figure 21: North America Market Value (US$ million) Forecast, 2023 to 2033 Figure 22: North America Market Value Share, By Product (2023 E) Figure 23: North America Market Value Share, By Indication (2023 E) Figure 24: North America Market Value Share, By End-user (2023 E) Figure 25: North America Market Value Share, by Country (2023 E) Figure 26: North America Market Attractiveness Analysis by Product, 2023 to 2033 Figure 27: North America Market Attractiveness Analysis by Indication, 2023 to 2033 Figure 28: North America Market Attractiveness Analysis by End-user, 2023 to 2033 Figure 29: North America Market Attractiveness Analysis by Country, 2023 to 2033 Figure 30: United States Market Value Proportion Analysis, 2022 Figure 31: Global Vs. United States Growth Comparison Figure 32: United States Market Share Analysis (%) By Product, 2023 to 2033 Figure 33: United States Market Share Analysis (%) By Indication, 2023 to 2033 Figure 34: United States Market Share Analysis (%) By End-user, 2023 to 2033 Figure 35: Canada Market Value Proportion Analysis, 2022 Figure 36: Global Vs. Canada. Growth Comparison Figure 37: Canada Market Share Analysis (%) By Product, 2023 to 2033 Figure 38: Canada Market Share Analysis (%) By Indication, 2023 to 2033 Figure 39: Canada Market Share Analysis (%) By End-user, 2023 to 2033 Figure 40: Latin America Market Value (US$ million) Analysis, 2018 to 2022 Figure 41: Latin America Market Value (US$ million) Forecast, 2023 to 2033 Figure 42: Latin America Market Value Share, By Product (2023 E) Figure 43: Latin America Market Value Share, By Indication (2023 E) Figure 44: Latin America Market Value Share, By End-user (2023 E) Figure 45: Latin America Market Value Share, by Country (2023 E) Figure 46: Latin America Market Attractiveness Analysis by Product, 2023 to 2033 Figure 47: Latin America Market Attractiveness Analysis by Indication, 2023 to 2033 Figure 48: Latin America Market Attractiveness Analysis by End-user, 2023 to 2033 Figure 49: Latin America Market Attractiveness Analysis by Country, 2023 to 2033 Figure 50: Mexico Market Value Proportion Analysis, 2022 Figure 51: Global Vs Mexico Growth Comparison Figure 52: Mexico Market Share Analysis (%) By Product, 2023 to 2033 Figure 53: Mexico Market Share Analysis (%) By Indication, 2023 to 2033 Figure 54: Mexico Market Share Analysis (%) By End-user, 2023 to 2033 Figure 55: Brazil Market Value Proportion Analysis, 2022 Figure 56: Global Vs. Brazil. Growth Comparison Figure 57: Brazil Market Share Analysis (%) By Product, 2023 to 2033 Figure 58: Brazil Market Share Analysis (%) By Indication, 2023 to 2033 Figure 59: Brazil Market Share Analysis (%) By End-user, 2023 to 2033 Figure 60: Argentina Market Value Proportion Analysis, 2022 Figure 61: Global Vs Argentina Growth Comparison Figure 62: Argentina Market Share Analysis (%) By Product, 2023 to 2033 Figure 63: Argentina Market Share Analysis (%) By Indication, 2023 to 2033 Figure 64: Argentina Market Share Analysis (%) By End-user, 2023 to 2033 Figure 65: Europe Market Value (US$ million) Analysis, 2018 to 2022 Figure 66: Europe Market Value (US$ million) Forecast, 2023 to 2033 Figure 67: Europe Market Value Share, By Product (2023 E) Figure 68: Europe Market Value Share, By Indication (2023 E) Figure 69: Europe Market Value Share, By End-user (2023 E) Figure 70: Europe Market Value Share, by Country (2023 E) Figure 71: Europe Market Attractiveness Analysis by Product, 2023 to 2033 Figure 72: Europe Market Attractiveness Analysis by Indication, 2023 to 2033 203 Figure 73: Europe Market Attractiveness Analysis by End-user, 2023 to 2033 Figure 74: Europe Market Attractiveness Analysis by Country, 2023 to 2033 Figure 75: United Kingdom Market Value Proportion Analysis, 2022 Figure 76: Global Vs. United Kingdom Growth Comparison Figure 77: United Kingdom Market Share Analysis (%) By Product, 2023 to 2033 Figure 78: United Kingdom Market Share Analysis (%) By Indication, 2023 to 2033 Figure 79: United Kingdom Market Share Analysis (%) By End-user, 2023 to 2033 Figure 80: Germany Market Value Proportion Analysis, 2022 Figure 81: Global Vs. Germany Growth Comparison Figure 82: Germany Market Share Analysis (%) By Product, 2023 to 2033 Figure 83: Germany Market Share Analysis (%) By Indication, 2023 to 2033 Figure 84: Germany Market Share Analysis (%) By End-user, 2023 to 2033 Figure 85: Italy Market Value Proportion Analysis, 2022 Figure 86: Global Vs. Italy Growth Comparison Figure 87: Italy Market Share Analysis (%) By Product, 2023 to 2033 Figure 88: Italy Market Share Analysis (%) By Indication, 2023 to 2033 Figure 89: Italy Market Share Analysis (%) By End-user, 2023 to 2033 Figure 90: France Market Value Proportion Analysis, 2022 Figure 91: Global Vs France Growth Comparison Figure 92: France Market Share Analysis (%) By Product, 2023 to 2033 Figure 93: France Market Share Analysis (%) By Indication, 2023 to 2033 Figure 94: France Market Share Analysis (%) By End-user, 2023 to 2033 Figure 95: Spain Market Value Proportion Analysis, 2022 Figure 96: Global Vs Spain Growth Comparison Figure 97: Spain Market Share Analysis (%) By Product, 2023 to 2033 Figure 98: Spain Market Share Analysis (%) By Indication, 2023 to 2033 Figure 99: Spain Market Share Analysis (%) By End-user, 2023 to 2033 Figure 100: Russia Market Value Proportion Analysis, 2022 Figure 101: Global Vs Russia Growth Comparison Figure 102: Russia Market Share Analysis (%) By Product, 2023 to 2033 Figure 103: Russia Market Share Analysis (%) By Indication, 2023 to 2033 Figure 104: Russia Market Share Analysis (%) By End-user, 2023 to 2033 Figure 105: BENELUX Market Value Proportion Analysis, 2022 Figure 106: Global Vs BENELUX Growth Comparison Figure 107: BENELUX Market Share Analysis (%) By Product, 2023 to 2033 Figure 108: BENELUX Market Share Analysis (%) By Indication, 2023 to 2033 Figure 109: BENELUX Market Share Analysis (%) By End-user, 2023 to 2033 Figure 110: East Asia Market Value (US$ million) Analysis, 2018 to 2022 Figure 111: East Asia Market Value (US$ million) Forecast, 2023 to 2033 Figure 112: East Asia Market Value Share, By Product (2023 E) Figure 113: East Asia Market Value Share, By Indication (2023 E) Figure 114: East Asia Market Value Share, By End-user (2023 E) Figure 115: East Asia Market Value Share, by Country (2023 E) Figure 116: East Asia Market Attractiveness Analysis by Product, 2023 to 2033 Figure 117: East Asia Market Attractiveness Analysis by Indication, 2023 to 2033 Figure 118: East Asia Market Attractiveness Analysis by End-user, 2023 to 2033 Figure 119: East Asia Market Attractiveness Analysis by Country, 2023 to 2033 Figure 120: China Market Value Proportion Analysis, 2022 Figure 121: Global Vs. China Growth Comparison Figure 122: China Market Share Analysis (%) By Product, 2023 to 2033 Figure 123: China Market Share Analysis (%) By Indication, 2023 to 2033 Figure 124: China Market Share Analysis (%) By End-user, 2023 to 2033 Figure 125: Japan Market Value Proportion Analysis, 2022 Figure 126: Global Vs. Japan Growth Comparison Figure 127: Japan Market Share Analysis (%) By Product, 2023 to 2033 Figure 128: Japan Market Share Analysis (%) By Indication, 2023 to 2033 Figure 129: Japan Market Share Analysis (%) By End-user, 2023 to 2033 Figure 130: South Korea Market Value Proportion Analysis, 2022 Figure 131: Global Vs South Korea Growth Comparison Figure 132: South Korea Market Share Analysis (%) By Product, 2023 to 2033 Figure 133: South Korea Market Share Analysis (%) By Indication, 2023 to 2033 Figure 134: South Korea Market Share Analysis (%) By End-user, 2023 to 2033 Figure 135: South Asia Market Value (US$ million) Analysis, 2018 to 2022 Figure 136: South Asia Market Value (US$ million) Forecast, 2023 to 2033 Figure 137: South Asia Market Value Share, By Product (2023 E) Figure 138: South Asia Market Value Share, By Indication (2023 E) Figure 139: South Asia Market Value Share, By End-user (2023 E) Figure 140: South Asia Market Value Share, by Country (2023 E) Figure 141: South Asia Market Attractiveness Analysis by Product, 2023 to 2033 Figure 142: South Asia Market Attractiveness Analysis by Indication, 2023 to 2033 Figure 143: South Asia Market Attractiveness Analysis by End-user, 2023 to 2033 Figure 144: South Asia Market Attractiveness Analysis by Country, 2023 to 2033 Figure 145: India Market Value Proportion Analysis, 2022 Figure 146: Global Vs. India Growth Comparison Figure 147: India Market Share Analysis (%) By Product, 2023 to 2033 Figure 148: India Market Share Analysis (%) By Indication, 2023 to 2033 Figure 149: India Market Share Analysis (%) By End-user, 2023 to 2033 Figure 150: Indonesia Market Value Proportion Analysis, 2022 Figure 151: Global Vs. Indonesia Growth Comparison Figure 152: Indonesia Market Share Analysis (%) By Product, 2023 to 2033 Figure 153: Indonesia Market Share Analysis (%) By Indication, 2023 to 2033 Figure 154: Indonesia Market Share Analysis (%) By End-user, 2023 to 2033 Figure 155: Malaysia Market Value Proportion Analysis, 2022 Figure 156: Global Vs. Malaysia Growth Comparison Figure 157: Malaysia Market Share Analysis (%) By Product, 2023 to 2033 Figure 158: Malaysia Market Share Analysis (%) By Indication, 2023 to 2033 Figure 159: Malaysia Market Share Analysis (%) By End-user, 2023 to 2033 Figure 160: Thailand Market Value Proportion Analysis, 2022 Figure 161: Global Vs. Thailand Growth Comparison Figure 162: Thailand Market Share Analysis (%) By Product, 2023 to 2033 Figure 163: Thailand Market Share Analysis (%) By Indication, 2023 to 2033 Figure 164: Thailand Market Share Analysis (%) By End-user, 2023 to 2033 Figure 165: Oceania Market Value (US$ million) Analysis, 2018 to 2022 Figure 166: Oceania Market Value (US$ million) Forecast, 2023 to 2033 Figure 167: Oceania Market Value Share, By Product (2023 E) Figure 168: Oceania Market Value Share, By Indication (2023 E) Figure 169: Oceania Market Value Share, By End-user (2023 E) Figure 170: Oceania Market Value Share, by Country (2023 E) Figure 171: Oceania Market Attractiveness Analysis by Product, 2023 to 2033 Figure 172: Oceania Market Attractiveness Analysis by Indication, 2023 to 2033 Figure 173: Oceania Market Attractiveness Analysis by End-user, 2023 to 2033 Figure 174: Oceania Market Attractiveness Analysis by Country, 2023 to 2033 Figure 175: Australia Market Value Proportion Analysis, 2022 Figure 176: Global Vs. Australia Growth Comparison Figure 177: Australia Market Share Analysis (%) By Product, 2023 to 2033 Figure 178: Australia Market Share Analysis (%) By Indication, 2023 to 2033 Figure 179: Australia Market Share Analysis (%) By End-user, 2023 to 2033 Figure 180: New Zealand Market Value Proportion Analysis, 2022 Figure 181: Global Vs New Zealand Growth Comparison Figure 182: New Zealand Market Share Analysis (%) By Product, 2023 to 2033 Figure 183: New Zealand Market Share Analysis (%) By Indication, 2023 to 2033 Figure 184: New Zealand Market Share Analysis (%) By End-user, 2023 to 2033 Figure 185: Middle East and Africa Market Value (US$ million) Analysis, 2018 to 2022 Figure 186: Middle East and Africa Market Value (US$ million) Forecast, 2023 to 2033 Figure 187: Middle East and Africa Market Value Share, By Product (2023 E) Figure 188: Middle East and Africa Market Value Share, By Indication (2023 E) Figure 189: Middle East and Africa Market Value Share, By End-user (2023 E) Figure 190: Middle East and Africa Market Value Share, by Country (2023 E) Figure 191: Middle East and Africa Market Attractiveness Analysis by Product, 2023 to 2033 Figure 192: Middle East and Africa Market Attractiveness Analysis by Indication, 2023 to 2033 Figure 193: Middle East and Africa Market Attractiveness Analysis by End-user, 2023 to 2033 Figure 194: Middle East and Africa Market Attractiveness Analysis by Country, 2023 to 2033 Figure 195: GCC Countries Market Value Proportion Analysis, 2022 Figure 196: Global Vs GCC Countries Growth Comparison Figure 197: GCC Countries Market Share Analysis (%) By Product, 2023 to 2033 Figure 198: GCC Countries Market Share Analysis (%) By Indication, 2023 to 2033 Figure 199: GCC Countries Market Share Analysis (%) By End-user, 2023 to 2033 Figure 200: Türkiye Market Value Proportion Analysis, 2022 Figure 201: Global Vs. Türkiye Growth Comparison Figure 202: Türkiye Market Share Analysis (%) By Product, 2023 to 2033 Figure 203: Türkiye Market Share Analysis (%) By Indication, 2023 to 2033 Figure 204: Türkiye Market Share Analysis (%) By End-user, 2023 to 2033 Figure 205: South Africa Market Value Proportion Analysis, 2022 Figure 206: Global Vs. South Africa Growth Comparison Figure 207: South Africa Market Share Analysis (%) By Product, 2023 to 2033 Figure 208: South Africa Market Share Analysis (%) By Indication, 2023 to 2033 Figure 209: South Africa Market Share Analysis (%) By End-user, 2023 to 2033 Figure 210: Northern Africa Market Value Proportion Analysis, 2022 Figure 211: Global Vs North Africa Growth Comparison Figure 212: North Africa Market Share Analysis (%) By Product, 2023 to 2033 Figure 213: North Africa Market Share Analysis (%) By Indication, 2023 to 2033 Figure 214: North Africa Market Share Analysis (%) By End-user, 2023 to 2033
Recommendations
Healthcare
Published : June 2023
Explore Healthcare Insights
View Reports